SV Life Sciences Fund IV (GP), L.P., 10% Owner at Ophthotech Corp. (OPHT), sold 653,418 shares at $39.87 ($26.3M) on 2014-05-27, disclosed to the SEC on 2014-05-29.
Open-market sale of $26.3M OPHT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.87 | 2,698 | $108K | 0.4% |
| 2 | $39.87 | 95,039 | $3.8M | 14.4% |
| 3 | $39.87 | 97,737 | $3.9M | 14.8% |
| 4 | $40.33 | 6,321 | $255K | 1.0% |
| 5 | $40.33 | 222,651 | $9.0M | 34.2% |
| 6 | $40.33 | 228,972 |
| $9.2M |
| 35.2% |
| Total | $40.19 avg | 653,418 | $26.3M | 100% |
| Filing → |
| NGSX | SELL | 2010-05-05 | $3.1M | — | Filing → |